D. Zemánek

J. Veselka, D. Zemánek, J. Honěk, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Coronary artery disease prediction based on breast arterial calcification in women undergoing mammography as a screening for breast cancer

Zhi Chen, D. Zemánek, T. Kovárník, 2021, Menopause.

Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.

M. Penicka, J. Veselka, P. Widimsky, 2009, Genetic testing and molecular biomarkers.

Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins

J. Veselka, P. Hájek, P. Tomašov, 2011, Archives of medical science : AMS.

Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.

M. Huptych, D. Zemánek, M. Balík, 2022, JAMA.

Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy

M. Penicka, J. Veselka, P. Widimsky, 2012, Acta cardiologica.

Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for detection of obstruction in hypertrophic cardiomyopathy

J. Veselka, T. Kara, P. Tomašov, 2015, Archives of medical science : AMS.

Effect of MGuard net protective stent on the release of troponin I in patients with acute coronary syndromes. A randomized controlled trial.

J. Veselka, P. Hájek, P. Tomašov, 2011, International heart journal.

Genetic Testing in the Management of Relatives of Patients with Hypertrophic Cardiomyopathy (echocardiography/DNAsequenceanalysis/cardiomyopathies)

M. Penicka, J. Veselka, P. Tomašov, 2014 .

Endothelial dysfunction assessed by digital tonometry and discrepancy between fraction flow reserve and instantaneous wave free ratio

M. Sonka, M. Mates, M. Branny, 2020, Acta cardiologica.

ResearchFluvastatin in the first-line therapy of acute coronary syndrome : results of the multicenter , randomized , double-blind , placebo-controlled trial ( the FACS-trial )

M. Macek, J. Veselka, P. Hájek, 2015 .

Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.

J. Veselka, P. Hájek, D. Zemánek, 2009, The American journal of cardiology.

Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.

J. Veselka, P. Hájek, P. Tomašov, 2011, The American journal of cardiology.

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.

S. Solomon, T. Abraham, P. Elliott, 2021, Journal of the American College of Cardiology.

(Appropriate indications to cardiac computed tomography (CT): expert consensus statement of the Section of Cardiac Computed Tomography of the Czech Association of Cardiovascular Imaging Methods of the Czech Society of Cardiology)

P. Kuchynka, D. Zemánek, J. Baxa, 2021, Cor et Vasa.

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

S. Solomon, M. Wheeler, T. Seidler, 2020, The Lancet.

Use of intravascular ultrasound in procedures involving the left main coronary artery

J. Veselka, P. Hájek, D. Zemánek, 2010 .

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic

J. Vondrak, D. Zemánek, M. Táborský, 2022, ESC heart failure.

Fractional Flow Reserve Versus Instantaneous Wave‐Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study

J. Mrózek, M. Mates, P. Kala, 2022, Journal of the American Heart Association.

Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.

J. Veselka, J. Krejčí, P. Tomašov, 2015, The Canadian journal of cardiology.

Survival of patients ≤ 50 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

J. Veselka, M. Branny, J. Krejčí, 2014, The Canadian journal of cardiology.

Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.

J. Veselka, M. Branny, J. Krejčí, 2013, The Canadian journal of cardiology.

Clinical Research Low Incidence of Procedure-Related Major Adverse Cardiac Events After Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy

J. Veselka, M. Branny, J. Krejčí, 2013 .

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective

J. Veselka, P. Tomašov, D. Zemánek, 2009, Heart and Vessels.

Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study.

J. Veselka, D. Zemánek, P. Červinka, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study).

J. Veselka, P. Hájek, M. Branny, 2014, The American journal of cardiology.

Coronary artery anomalies — a short review

J. Veselka, D. Zemánek, 2007 .

(Hypertrophic cardiomyopathy and sports - is it time for a change in strategy?)

D. Zemánek, 2020, Cor et Vasa.

Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years.

J. Veselka, P. Tomašov, D. Zemánek, 2011, The Canadian journal of cardiology.

Extracorporeal versus conventional cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: a secondary analysis of the Prague OHCA trial

M. Huptych, D. Zemánek, S. Havranek, 2022, Critical Care.

Sudden death risk stratification in hypertrophic cardiomyopathy

J. Veselka, D. Zemánek, S. Homolová, 2009 .

J. Veselka, P. Hájek, D. Zemánek, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Presence of the viral genome in the myocardial tissue of patients without clinical suspicion of myocarditis.

P. Hubáček, J. Veselka, D. Zemánek, 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy

J. Veselka, J. Sitar, M. Branny, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.

J. Veselka, P. Tomašov, D. Zemánek, 2015, International journal of cardiology.

Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart block.

J. Veselka, J. Krejčí, P. Tomašov, 2014, International journal of cardiology.

Feasibility of Brachial Occlusion Technique for Beat-to-Beat Pulse Wave Analysis

Bruce D. Johnson, D. Zemánek, P. Šajgalík, 2022, Sensors.

Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17.

P. Neužil, P. Peichl, P. Kala, 2021, Journal of the American College of Cardiology.

Early opening of dormant septal collaterals during alcohol septal ablation: a possible hazard of remote necrosis.

J. Veselka, P. Tomašov, D. Zemánek, 2013, The Canadian journal of cardiology.

The anomalous origin of the left coronary artery from the right aortic sinus: is the coronary angiography still a ‘gold standard’?

J. Veselka, D. Zemánek, D. Tesař, 2006, The International Journal of Cardiovascular Imaging.

Usefulness of Alcohol Septal Ablation in the Left Ventricular Outflow Tract Obstruction in Fabry Disease Cardiomyopathy.

D. Zemánek, A. Linhart, J. Marek, 2021, The American journal of cardiology.

Development and Testing of Castables with Low Content of Calcium Oxide

D. Zemánek, L. Nevřivová, 2022, Materials.

Development and Properties of New Mullite Based Refractory Grog

P. Štursa, D. Zemánek, D. Všianský, 2021, Materials.

Vulnerable atherosclerotic plaque - a review of current concepts and advanced imaging.

M. Hutyra, D. Zemánek, M. Táborský, 2018, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Variants in miRNA Regulating Cardiac Growth Are Not a Common Cause of Hypertrophic Cardiomyopathy

J. Veselka, P. Widimsky, P. Tomašov, 2015, Cardiology.

Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy.

J. Veselka, P. Tomašov, D. Zemánek, 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

Combined valve replacement and aortocoronary bypass in an adult mucopolysaccharidosis type VII patient.

P. Kuchynka, M. Tesařová, J. Zeman, 2020, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Comparison of carotid artery stenting in patients with single versus bilateral carotid artery disease and factors affecting midterm outcome.

J. Veselka, P. Hájek, P. Tomašov, 2011, Annals of vascular surgery.

Real-time myocardial contrast echocardiography for echo-guided alcohol septal ablation

J. Veselka, D. Zemánek, 2009 .

Uncommon cause of obstruction in the left ventricular outflow tract by a metastasis of adenocarcinoma

J. Veselka, D. Zemánek, J. Ferda, 2010, Archives of medical science : AMS.

Current options of transcatheter mitral valve implantation

D. Zemánek, T. Paleček, T. Kovárník, 2023, Intervenční a akutní kardiologie.

Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.

J. Veselka, P. Hájek, M. Branny, 2013, International journal of cardiology.

Evaluation of the right ventricular function in hypertrophic obstructive cardiomyopathy: a strain and tissue Doppler study.

J. Veselka, P. Tomašov, D. Zemánek, 2010, Physiological research.

PEDIATRIC AND CONGENITAL HEART DISEASE Original Studies Complications of Low-Dose, Echo-Guided Alcohol Septal Ablation

J. Veselka, P. Tomašov, D. Zemánek, 2010 .

Mid-term outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum.

J. Veselka, P. Tomašov, D. Zemánek, 2012, The Journal of invasive cardiology.

Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy

J. Veselka, J. Krejčí, D. Zemánek, 2013, TheScientificWorldJournal.

Feasibility, safety, and early outcomes of direct carotid artery stent implantation with use of the FilterWire EZ™ Embolic Protection System

J. Veselka, P. Hájek, D. Zemánek, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

J. Veselka, D. Zemánek, D. Tesař, 2004, Kardiologia polska.

Coronary angiography and percutaneous coronary intervention in cardiac arrest patients without return of spontaneous circulation.

D. Zemánek, S. Havranek, A. Linhart, 2022, Resuscitation.

Comparison of mid-term outcomes of carotid artery stenting for moderate versus critical stenosis

J. Veselka, P. Hájek, P. Tomašov, 2011, Archives of medical science : AMS.

Thirty-day outcomes of direct carotid artery stenting with cerebral protection in high-risk patients.

J. Veselka, P. Hájek, D. Zemánek, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Corrosion Properties of Castables with Various Calcium Oxide Content

D. Zemánek, L. Nevřivová, 2022, Materials Science Forum.

Use of the sol-gel method for the production of no cement castables

D. Zemánek, L. Nevřivová, 2021 .